Delivery Order SPE2DB22D3301-SPE2DB25FX5GF

Award Date 11/11/24
Potential Completion Date 11/12/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,315.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 3, 2025 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,474.24 firm-fixed-price delivery order is for the supply of VIGAMOX 0.5% eye drops (3ml), with an ultimate completion date of June 5, 2025. The contract is not set aside and was awarded on June 4, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $2,686.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vigamox 0.5% eye drops. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,648.32 firm fixed-price delivery order contract is for the supply of VIGAMOX 0.5% eye drops, with a period of performance through March 14, 2024. The contract is not designated as a set-aside and was awarded competitively. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. government has awarded a Delivery Order contract worth $2,754.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Vigamox 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
This federal contract award, valued at $10,643.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product used in medical treatment. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $2,073.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIGAMOX 0.5% eye drops, a medical product used to treat eye infections. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 18, 2024, with a ceiling value of $3,104.66 and a completion date of July 19, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award, valued at $7,699.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VIGAMOX 0.5% eye drops (3ml). The contract has a ceiling value of $24,793.95 and a period of performance through June 12, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5GF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $10,073.35 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIGAMOX 0.5% eye drops (3 mL). This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of November 12, 2024 and does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:33 PM